IMTX Immatics N.V. - Ordinary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 5, 2026
$7.59
· of 52w range
· above low
· to high
$7.4152w low
$12.4152w high
P/E
-6.5
EPS
$-1.61
your badges
52W Range
$7–$12
Analyst Rating
BUY
Price Target
$18
P/E
-6.5
ROE
-37.1%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
IMTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$7.59
P/E
-6.5
EPS
$-1.61
ROE
-37.1%
52W Range
$7–$12
IMTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-1.612020-12-31 → 2025-12-31
Free Cash Flow$-183M2020-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | IMTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -6.5 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | IMTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -31.2% | · | -31.2% | In line | |
| ROE | -37.1% | · | -37.1% | In line | |
| ROIC | -37.2% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | IMTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 11.7 | · | 7.5 | Strong liquidity | |
| Quick Ratio | 8.0 | · | 4.5 | Strong liquidity | |
| Interest Coverage | -192.4 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-11.5%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 18, 2026 | $-0.46 | $-0.44 | -5.7% |
| March 31, 2026 | May 11, 2026 | $-0.43 | $-0.41 | -4.9% |
| Dec. 31, 2025 | $-0.29 | $-0.38 | 24.4% | |
| Sept. 30, 2025 | $-0.42 | $-0.40 | -5.6% | |
| June 30, 2025 | $-0.58 | $-0.33 | -77.7% | |
| March 31, 2025 | $-0.33 | $-0.33 | 0.45% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $184M | $148M | $119M | $107M | $88M | $67M | $40M | $34M | |
| SG&A Expense | $51M | $46M | $38M | $36M | $34M | $34M | $12M | $8M | |
| Operating Income | $-182M | $-39M | $-102M | $30M | $-86M | $-70M | $-33M | $-34M | |
| Interest Expense | $946.0K | $886.0K | $831.0K | $1M | $566.0K | $289.0K | $264.0K | $161.0K | |
| Interest Income | $19M | $44M | $14M | $9M | $6M | $3M | $790.0K | $2M | |
| Pretax Income | $-198M | $21M | $-97M | $42M | $-93M | $-212M | $-32M | $-32M | |
| Income Tax | $-2M | $6M | $-2M | $14M | $0 | $0 | $0 | $0 | |
| Net Income | $-196M | $15M | $-95M | $28M | $-93M | $-211M | $-32M | $-31M | |
| EPS (Basic) | $-1.61 | $0.14 | $-1.18 | $0.41 | $-1.48 | $-4.40 | · | · | |
| EPS (Diluted) | $-1.61 | $0.14 | $-1.18 | $0.40 | $-1.48 | $-4.40 | · | · | |
| Shares (Basic) | 122,348,434 | 105,744,929 | 80,546,682 | 67,220,824 | 62,912,921 | 48,001,228 | 33,093,838 | 33,093,838 | |
| Shares (Diluted) | 122,348,434 | 106,795,100 | 80,546,682 | 68,824,906 | 62,912,921 | 48,001,228 | · | · | |
| EBITDA | $-182M | $-39M | $-102M | $30M | $-86M | $-70M | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $346M | $237M | $218M | $149M | $133M | $208M | $103M | $39M | |
| Current Assets | $504M | $630M | $449M | $377M | $152M | $239M | $124M | · | |
| PP&E (Net) | $42M | $50M | $44M | $13M | $11M | $8M | $5M | · | |
| Intangibles | $2M | $2M | $2M | $2M | $1M | $914.0K | $1M | · | |
| Total Assets | $562M | $696M | $510M | $408M | $175M | $255M | $134M | · | |
| Current Liabilities | $43M | $68M | $157M | $106M | $95M | $77M | $69M | · | |
| Total Liabilities | · | · | $292M | $204M | · | $167M | · | · | |
| Retained Earnings | $-786M | $-590M | $-605M | $-510M | $-538M | $-444M | $-233M | · | |
| Stockholders' Equity | $484M | $575M | $218M | $203M | $24M | $87M | $-41M | $-9M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-177M | $-158M | $18M | $100M | $-85M | $-81M | $71M | $21M | |
| CapEx | $7M | $16M | $31M | $6M | $5M | $7M | $2M | $429.0K | |
| Investing Cash Flow | $205M | $-152M | $-31M | $-210M | $7M | $-16M | $-5M | $-14M | |
| Financing Cash Flow | $97M | $320M | $85M | $124M | $-3M | $208M | $-2M | $24M | |
| Free Cash Flow | $-183M | $-174M | $-13M | $94M | $-87M | $-93M | · | · | |
| Levered FCF | $-184M | $-175M | $-13M | $93M | $-89M | $-103M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -31.2% | · | -21.1% | 12.9% | -43.5% | -108.7% | · | · | |
| ROE | -37.1% | · | -45.3% | 31.6% | -167.5% | -907.7% | · | · | |
| ROIC | -37.2% | · | -45.2% | 12.5% | -358.6% | -79.8% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.7 | 9.3 | 2.9 | 3.5 | 1.6 | 3.1 | · | · | |
| Quick Ratio | 8.0 | 3.5 | 1.4 | 1.4 | 1.4 | 2.7 | · | · | |
| Interest Coverage | -192.4 | -43.6 | -122.4 | 28.9 | -50.0 | -6.9 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | $-1.44 | $-1.48 | $0.23 | $1.45 | · | · | · | · | |
| EPS (TTM) | $-1.61 | $0.14 | $-1.18 | $0.40 | $-1.48 | $-4.40 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-196M | $15M | $-95M | $28M | $-93M | $-211M | · | · | |
| P/E | -6.5 | 50.8 | -8.9 | 21.8 | -9.1 | -2.5 | · | · | |
| Earnings Yield | -15.3% | 2.0% | -11.2% | 4.6% | -11.0% | -40.8% | · | · |
Income Statement
| Metric | Trend | Q4 2025 | Q1 2024 |
|---|---|---|---|
| Pretax Income | · | $-2M | |
| Income Tax | · | $518.0K | |
| Net Income | · | $-2M | |
| EPS (Basic) | · | $-0.02 | |
| EPS (Diluted) | · | $-0.03 | |
| Shares (Basic) | · | 98,740,222 | |
| Shares (Diluted) | · | 105,927,222 |
Cash Flow
| Metric | Trend | Q4 2025 | Q1 2024 |
|---|---|---|---|
| Operating Cash Flow | · | $-33M | |
| Investing Cash Flow | · | $-242M | |
| Financing Cash Flow | · | $175M |
Per Share
| Metric | Trend | Q4 2025 | Q1 2024 |
|---|---|---|---|
| EPS (TTM) | $-1.61 | · |
Valuation (TTM)
| Metric | Trend | Q4 2025 | Q1 2024 |
|---|---|---|---|
| Net Income TTM | $-196M | · | |
| P/E | -6.5 | · | |
| Earnings Yield | -15.3% | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|
| Net Income | $-196M | $15M | · | · | · |
| Diluted EPS | $-1.61 | $0.14 | · | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|
| Current Ratio | 11.7 | 9.3 | · | · | · |
| Quick Ratio | 8.0 | 3.5 | · | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-183M | $-174M | · | · | · |
Institutional owners (13F) 85 filers · $779.6M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
85
Value held
$779.6M
New positions
12
Exited positions
13
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 12 (-2 vs prior Q) | 13 (+6 vs prior Q) | 24 (-5 vs prior Q) | 33 (+10 vs prior Q) | -8.8M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $131,144,763 | 12,946,176 | 16.82% | Shares |
| MONTANOVA CAPITAL, LLC | $113,356,007 | 11,190,129 | 14.54% | Shares |
| PERCEPTIVE ADVISORS LLC | $105,184,409 | 10,383,456 | 13.49% | Shares |
| BAKER BROS. ADVISORS LP | $96,321,763 | 9,508,565 | 12.35% | Shares |
| Jefferies Financial Group Inc. | $65,913,904 | 6,506,802 | 8.45% | Shares |
| Vestal Point Capital, LP | $62,552,750 | 6,175,000 | 8.02% | Shares |
| Sofinnova Investments, Inc. | $37,170,475 | 3,669,346 | 4.77% | Shares |
| MORGAN STANLEY | $22,149,185 | 2,186,494 | 2.84% | Shares |
| CITADEL ADVISORS LLC | $18,382,475 | 1,814,657 | 2.36% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $16,692,740 | 1,647,852 | 2.14% | Shares |
| Point72 Asset Management, L.P. | $14,684,418 | 1,449,597 | 1.88% | Shares |
| Woodline Partners LP | $9,124,456 | 900,736 | 1.17% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $7,294,177 | 720,057 | 0.94% | Shares |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | $7,064,976 | 697,431 | 0.91% | Shares |
| Aberdeen Group plc | $6,621,009 | 653,604 | 0.85% | Shares |
| Qube Research & Technologies Ltd | $5,300,188 | 523,217 | 0.68% | Shares |
| Boxer Capital Management, LLC | $4,811,750 | 475,000 | 0.62% | Shares |
| WASATCH ADVISORS LP | $4,573,858 | 464,823 | 0.59% | Shares |
| TD Asset Management Inc | $4,551,895 | 449,348 | 0.58% | Shares |
| STATE STREET CORP | $4,251,541 | 419,698 | 0.55% | Shares |
| Balyasny Asset Management L.P. | $4,068,644 | 401,643 | 0.52% | Shares |
| GOLDMAN SACHS GROUP INC | $3,891,652 | 384,171 | 0.50% | Shares |
| SECTORAL ASSET MANAGEMENT INC | $2,278,521 | 224,928 | 0.29% | Shares |
| Atom Investors LP | $2,191,777 | 216,365 | 0.28% | Shares |
| MOORE CAPITAL MANAGEMENT, LP | $1,952,760 | 192,770 | 0.25% | Shares |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1,886,188 | 197,300 | 0.24% | Shares |
| Burkehill Global Management, LP | $1,519,500 | 150,000 | 0.19% | Shares |
| SummitTX Capital, L.P. | $1,482,536 | 146,351 | 0.19% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,432,382 | 141,400 | 0.18% | Shares |
| Aquilo Capital Management, LLC | $1,375,108 | 304,902 | 0.18% | Shares |
| ALPS ADVISORS INC | $1,373,618 | 135,599 | 0.18% | Shares |
| JPMORGAN CHASE & CO | $1,310,427 | 137,074 | 0.17% | Shares |
| MYDA Advisors LLC | $1,215,600 | 120,000 | 0.16% | Shares |
| DAFNA Capital Management LLC | $1,184,805 | 116,960 | 0.15% | Shares |
| Jump Financial, LLC | $1,074,246 | 106,046 | 0.14% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,060,712 | 104,710 | 0.14% | Shares |
| JANE STREET GROUP, LLC | $1,059,071 | 104,548 | 0.14% | Shares |
| CITIGROUP INC | $678,031 | 66,933 | 0.09% | Shares |
| TUDOR INVESTMENT CORP ET AL | $672,976 | 66,434 | 0.09% | Shares |
| D. E. Shaw & Co., Inc. | $599,301 | 59,161 | 0.08% | Shares |
| MACQUARIE GROUP LTD | $541,955 | 53,500 | 0.07% | Shares |
| Engineers Gate Manager LP | $515,475 | 50,886 | 0.07% | Shares |
| Vanguard Personalized Indexing Management, LLC | $500,067 | 49,365 | 0.06% | Shares |
| Ikarian Capital, LLC | $492,003 | 48,569 | 0.06% | Shares |
| BARCLAYS PLC | $468,665 | 46,265 | 0.06% | Shares |
| BANK OF AMERICA CORP /DE/ | $442,245 | 43,657 | 0.06% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $438,599 | 43,297 | 0.06% | Shares |
| MILLENNIUM MANAGEMENT LLC | $408,239 | 40,300 | 0.05% | Put option |
| Prime Capital Investment Advisors, LLC | $405,200 | 40,000 | 0.05% | Shares |
| NORTHERN TRUST CORP | $365,977 | 36,128 | 0.05% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Joseph Edelman, Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. | Aug. 27, 2026 | 7.60% | Amendment | · | SEC |
| Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd., Joseph Edelman ×2 filings | Oct. 17, 2024 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 10 insiders · 1 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| James Nelson Pepin | Gen Counsel and Corp Secretary | Aug. 14, 2026 A | · | 0 | 0 | $0 |
| Peter Alan Chambre | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Mathias Hothum | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Eliot Forster | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Alise Reicin | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Adam Leo Stone | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Paul Rutherford Carter | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Heather L Mason | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Perceptive Advisors LLC | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Michael G Atieh | Director | June 16, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
IMTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 16 analysts
BUY
Median target
$17.00
+124.0%
7 43.8%
Strong Buy
8 50.0%
Buy
1 6.2%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
6 analysts · 2026-10-01Mean target $17.63 +132.3%
← Below all targets
Current price $7.59
Low$11.80
Mean$17.63
High$25.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 5, 2026